Skip to main content

**DISCLAIMER- All products shown here are investigational and therefore limited information is available on the site.

 

About Us

Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.

Investors, please visit our Investor section.

More About Marizyme

 

 

Our Products

 

01DuraGraft

DuraGraft®, is an investigational product used during Coronary Artery Bypass Grafting (CABG) surgery. DuraGraft is not yet approved in the US.

Learn More
group 4598

 

 

Our Pipeline Products / Technologies

 

 

02Krillase

Krillase-based MAR-VT-001®, a patent pending investigational product, based on extracts from Antarctic krill that contain proteolytic enzymes designed for veterinary dental indications to maintain dental health by reducing plaque and tartar. Krillase is not yet approved by the US FDA.

Learn More
group 1932
 

03MATLOC

A patent-pending proprietary investigational device based on lab-on chip technology for point-of-care, CKD assessment. MATLOC is not yet approved in the US.

Learn More
 
group 103
group 98

QUICK LINKS

 
Corporate
Presentation